ASPI

425 - ASP Isotopes Inc. (0001921865) (Filed by)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

425 - ASP Isotopes Inc. (0001921865) (Filed by)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is expected to be among the first new liquid helium supply to enter the market at a time of acute global shortage The Company remains on track to deliver liquid helium to customers during September and ramp production to nameplate capacity during 2H Following the successful start-up of Phase 1, the Company expects to advance to Phase 2 during 2H 2026. The Company is currently exploring ways to accelerate the revenues and cash flows from Phase 2 DALLAS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- ASP Iso

MIAMI, Aug. 19, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 95th Emerging Growth Conference on August 19 & 20, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter All times are in Eastern Time Presenting Today – Wednesday August 19, 2026 8:30Virtual Lobby opens.Register for the Con

8-K - ASP Isotopes Inc. (0001921865) (Filer)

DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("we," "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, is evaluating metal conversion opportunities in Namibia. As part of this evaluation, a public environmental and social impact assessment and consultation process has commenced for a proposed pilot-scale hydrofluorination and fluorination facility in the Walvis Bay area of Namibia. The proposed facility would be used to develop, test and demonstrate hydrofluorination an

MIAMI, Aug. 18, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 95th Emerging Growth Conference on August 19 & 20, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter All times are in Eastern Time Day 1 - WednesdayAugust 19, 2026 8:30Virtual Lobby opens.Register for the Conference. I

10-Q - ASP Isotopes Inc. (0001921865) (Filer)

425 - ASP Isotopes Inc. (0001921865) (Filed by)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, establishing a multi-year contracted cash flow supporting Phase 1 commercial operations, which remain targeted for completion in the third quarter of 2026 The LNG sale and purchase agreement, which is a five-year take-or-pay contract, is priced at greater than $16 /GJ (0.9478 MMBtu) of LNG, at current exchange rates Following the execution of this contract, Renergen has now secured take-or-pay contracts to support approximately 75% of the LNG volumes anticipated from Phase 1 The Company is

425 - ASP Isotopes Inc. (0001921865) (Filed by)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will host investor meetings at Citi's 2026 Natural Resources Conference on Thursday, August 13, 2026, in Las Vegas, Nevada. The latest investor presentation can be accessed under the Investors tab on the ASP Isotopes website. About ASP Isotopes Inc. ASP Isotopes is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, ne

425 - ASP Isotopes Inc. (0001921865) (Filed by)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes", "ASPI" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today released the following letter to shareholders from its Executive Chairman and Chief Executive Officer, Paul Mann. Dear Fellow Shareholder, As we prepare to announce financial results for the second quarter of 2026, I wanted to take this opportunity to update you on the developments taking place at ASP Isotopes Inc. All of our business units are making considerable progress, group revenues are increasing, and three of ou

Aeternum Health will change its name to Aeternum Resources and seeks to become a Strategic Supplier of Critical Materials.  Appoints Paul Mann as President and Executive Chairman and Josua Oosthuizen as Chief Executive Officer.  Raised over $4 million in financing to accelerate the progress on a tin and niobium mine in Nigeria, which is expected to enter commercial production during 1H 2027. Long lead-time items have been secured, access road constructed, geological surveys successfully conducted and critical infrastructure installed to accelerate initial production. WASHINGTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aeternum Health (OTC:AETN) ("Company"), today announced a change in strategy

8-K - ASP Isotopes Inc. (0001921865) (Filer)

DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Viktor Petkov, Chief Commercial Officer, will deliver a company presentation on Wednesday, August 12, 2026, at 8:00 a.m. ET. A live audio webcast of the presentation will be available in the Investors section of the Company’s website at www.aspisotopes.com. A replay will be available on the Company’s website within 48 hours after the event. About ASP Isotopes Inc. ASP Isotopes is developing a differentiated isoto

8-K - ASP Isotopes Inc. (0001921865) (Filer)

DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, beginning at 10:00 a.m. ET (3:00 p.m. BST). During the event, leadership will provide a comprehensive update on the Company’s strategic direction and commercial momentum, including a deep dive into nuclear medicine, electronic gases, and nuclear fuels, as well as the long-term market opportunity in each. Event Access and Registration The

425 - ASP Isotopes Inc. (0001921865) (Filed by)